{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:08:36Z","timestamp":1790842116195,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/ki.2015.305","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T11:56:12Z","timestamp":1444218972000},"page":"1233-1239","source":"Crossref","is-referenced-by-count":99,"title":["Molecular mechanisms of insulin resistance in chronic kidney disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Sandhya S.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Mitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2015.305_bb0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2522\/ptj.20080018","article-title":"Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise","volume":"88","author":"Turcotte","year":"2008","journal-title":"Phys Ther"},{"key":"10.1038\/ki.2015.305_bb0015","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI29024","article-title":"Insulin resistance and atherosclerosis","volume":"116","author":"Semenkovich","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1681\/ASN.2004100842","article-title":"Chronic kidney disease causes defects in signaling through the insulin receptor substrate\/phosphatidylinositol 3-kinase\/Akt pathway: implications for muscle atroply","volume":"17","author":"Bailey","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MNH.0b013e32834b23c1","article-title":"Measurement of insulin resistance in chronic kidney disease","volume":"20","author":"Pham","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2015.305_bb0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","article-title":"Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease","volume":"53","author":"Fliser","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI110067","article-title":"Insulin resistance in uremia","volume":"67","author":"DeFronzo","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0040","first-page":"e87","article-title":"Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors","volume":"261","author":"Friedman","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2015.305_bb0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ki.1982.132","article-title":"Insulin resistance in uremia mediated by postbinding defects","volume":"22","author":"Smith","year":"1982","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI112924","article-title":"Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: the influence of metabolic acidosis","volume":"79","author":"May","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1038\/ki.2015.305_bb0060","first-page":"7650","article-title":"Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice","volume":"119","author":"Hu","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","article-title":"IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting","volume":"20","author":"Zhang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0070","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2337\/diab.28.12.1095","article-title":"Glucose intolerance and aging: evidence for tissue insensitivity to insulin","volume":"28","author":"DeFronzo","year":"1979","journal-title":"Diabetes"},{"key":"10.1038\/ki.2015.305_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ki.2014.1","article-title":"Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function","volume":"86","author":"Jia","year":"2014","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0080","first-page":"e328","article-title":"Glucose intolerance following chronic metabolic acidosis in man","volume":"236","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2015.305_bb0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2337\/diab.30.5.387","article-title":"Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp","volume":"30","author":"Greenfield","year":"1981","journal-title":"Diabetes"},{"key":"10.1038\/ki.2015.305_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2015.305_bb0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","article-title":"The insulin resistance syndrome: definition and dietary approaches to treatment","volume":"25","author":"Reaven","year":"2005","journal-title":"Annu Rev Nutr"},{"key":"10.1038\/ki.2015.305_bb0100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBPdelta to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab"},{"key":"10.1038\/ki.2015.305_bb0105","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2006-0251","article-title":"Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2015.305_bb0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/CIRCULATIONAHA.112.000682","article-title":"Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis","volume":"127","author":"Ganda","year":"2013","journal-title":"Circulation"},{"key":"10.1038\/ki.2015.305_bb0115","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1681\/ASN.V73479","article-title":"Plasma lipopolysaccharide binding protein and bactericidal\/permeability increasing factor in CRF and HD patients","volume":"7","author":"Pereira","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0125","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistence","volume":"95","author":"Hotamisligil","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1038\/ki.2015.305_bb0135","doi-asserted-by":"crossref","first-page":"26055","DOI":"10.1016\/S0021-9258(19)74276-8","article-title":"Tumor necrosis factor-a suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates","volume":"268","author":"Feinstein","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2015.305_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1523-1755.1998.00981.x","article-title":"Immunologic function and survival in hemodialysis patients","volume":"54","author":"Kimmel","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0145","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/ndt\/gfq557","article-title":"Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-alpha are similarly associated with survival in haemodialysis patients","volume":"26","author":"Meuwese","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2015.305_bb0150","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.10-176917","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"FASEB J"},{"key":"10.1038\/ki.2015.305_bb0155","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.numecd.2011.01.005","article-title":"Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients","volume":"22","author":"Spoto","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1038\/ki.2015.305_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2013.97","article-title":"Signal regulatory protein-alpha interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease","volume":"84","author":"Thomas","year":"2013","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"p-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0170","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1101\/gad.1550907","article-title":"Mechanisms of obesity-associated insulin resistance: many choices on the menu","volume":"21","author":"Qatanani","year":"2007","journal-title":"Genes Dev"},{"key":"10.1038\/ki.2015.305_bb0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9343(82)90523-X","article-title":"Disorders of body fluids, sodium and potassium in chronic renal failure","volume":"72","author":"Mitch","year":"1982","journal-title":"Am J Med"},{"key":"10.1038\/ki.2015.305_bb0180","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2014.348","article-title":"Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans","volume":"87","author":"Hosoya","year":"2014","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI37672","article-title":"Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure","volume":"120","author":"D'Apolito","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.V84632","article-title":"Correction of acidosis in hemodialysis decreases whole-body protein degradation","volume":"8","author":"Graham","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0195","first-page":"e121","article-title":"Insulin mediated changes in protein degradation and glucose utilization following correction of acidosis in humans with CRF","volume":"268","author":"Reaich","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2015.305_bb0200","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.jrn.2008.08.010","article-title":"The influence of renal function and the diet on acid-base status in chronic kidney disease patients","volume":"19","author":"Leal","year":"2009","journal-title":"J Renal Nutr"},{"key":"10.1038\/ki.2015.305_bb0210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1681\/ASN.2014020205","article-title":"Current status of bicarbonate in CKD","volume":"26","author":"Dobre","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ki.2011.313","article-title":"Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy","volume":"81","author":"Goraya","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.305_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2015.305_bb0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI22324","article-title":"Muscle-specific expression of insulin-like growth factor-1 blocks angiotensin II-induced skeletal muscle wasting","volume":"115","author":"Song","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0230","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1681\/ASN.2006010083","article-title":"Protein degradation by the ubiquitin-proteasome pathway in normal and disease states","volume":"17","author":"Lecker","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.305_bb0235","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJM199612193352507","article-title":"Mechanisms of muscle wasting: the role of the ubiquitin-proteasome system","volume":"335","author":"Mitch","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2015.305_bb0240","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ijo.0802017","article-title":"The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome\u2013an analysis by structural equation modelling","volume":"26","author":"Chan","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1038\/ki.2015.305_bb0245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1073\/pnas.95.1.114","article-title":"Twenty proteins containing a C-terminal SOCS box form five structural classes","volume":"95","author":"Hilton","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2015.305_bb0250","doi-asserted-by":"crossref","first-page":"47944","DOI":"10.1074\/jbc.M104602200","article-title":"SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice","volume":"276","author":"Emanuelli","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2015.305_bb0255","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1242\/jcs.113.16.2813","article-title":"SOCS: physiological suppressors of cytokine signaling","volume":"113","author":"Krebs","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1038\/ki.2015.305_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","article-title":"A negative regulation of cytokine signaling pathways","volume":"18","author":"Yasukawa","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/ki.2015.305_bb0265","doi-asserted-by":"crossref","first-page":"25889","DOI":"10.1074\/jbc.M010579200","article-title":"Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance","volume":"276","author":"Mooney","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2015.305_bb0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.193.2.263","article-title":"Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)\/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation","volume":"193","author":"Kawazoe","year":"2001","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2015.305_bb0275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fonc.2012.00010","article-title":"The role of elongin BC-containing ubiquitin ligases","volume":"2","author":"Okumura","year":"2012","journal-title":"Front Oncol"},{"key":"10.1038\/ki.2015.305_bb0280","doi-asserted-by":"crossref","first-page":"40362","DOI":"10.1074\/jbc.M105332200","article-title":"Regulation of insulin\/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-1","volume":"276","author":"Rui","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2015.305_bb0285","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2015.305_bb0290","doi-asserted-by":"crossref","unstructured":"Bonala S, Lokireddy S, McFarlane C et al. Myostatin induces insulin resistance via casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake. J Biol Chem 289: 7654\u20137670.","DOI":"10.1074\/jbc.M113.529925"},{"key":"10.1038\/ki.2015.305_bb0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbamcr.2012.10.010","article-title":"Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases","volume":"1833","author":"Mohapatra","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/ki.2015.305_bb0300","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/MCB.01347-08","article-title":"Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading","volume":"29","author":"Nakao","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2015.305_bb0305","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI21480","article-title":"c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action","volume":"114","author":"Molero","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2015.305_bb0310","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.2337\/db06-0955","article-title":"Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action","volume":"55","author":"Molero","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/ki.2015.305_bb0315","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diabetes.55.03.06.db05-0312","article-title":"Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance","volume":"55","author":"Molero","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/ki.2015.305_bb0320","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/epr.10.87","article-title":"Lipid raft proteome reveals that oxidative phosphorylation system is associated with the plasma membrane","volume":"7","author":"Kim","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"10.1038\/ki.2015.305_bb0325","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nature11834","article-title":"Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders","volume":"494","author":"Song","year":"2013","journal-title":"Nature"},{"key":"10.1038\/ki.2015.305_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2008.01.032","article-title":"Identification and functional analysis of CBLB mutations in type 1 diabetes","volume":"368","author":"Yokoi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2015.305_bb0335","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/ncomms3354","article-title":"MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling","volume":"4","author":"Yi","year":"2013","journal-title":"Nat Commun"},{"key":"10.1038\/ki.2015.305_bb0340","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.devcel.2011.09.011","article-title":"The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling","volume":"21","author":"Shi","year":"2011","journal-title":"Dev Cell"},{"key":"10.1038\/ki.2015.305_bb0345","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.molcel.2008.03.009","article-title":"The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation","volume":"30","author":"Xu","year":"2008","journal-title":"Mol Cell"},{"key":"10.1038\/ki.2015.305_bb0350","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1042\/BST20130018","article-title":"Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2)","volume":"41","author":"Destefano","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1038\/ki.2015.305_bb0355","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/db12-0337","article-title":"Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes","volume":"62","author":"Mashili","year":"2013","journal-title":"Diabetes"}],"updated-by":[{"DOI":"10.1016\/j.kint.2015.11.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000}}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815610705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815610705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T16:00:33Z","timestamp":1653235233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815610705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0085253815610705"],"URL":"https:\/\/doi.org\/10.1038\/ki.2015.305","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}